The pathological mechanism of MetS causing CRC is not fully understood, it may be mediated by the dysregulation of growth signals such as insulin growth factor I (IGF-I), cytokines, and vascular integrity factors, which contribute to cancer-related processes [39]. This evidence concerns the gene IGF1 and metabolic syndrome.